Aligned Bio

Aligned Bio is a Lund-based nanotechnology company developing a nanowire-based biosensor platform for highly sensitive disease diagnostics and genome sequencing. Using a patented Aerotaxy nanowire production process, its technology achieves 10–100x higher diagnostic sensitivity compared to existing commercial sensors, with applications in cancer detection and DNA analysis. Backed by SmiLe Inject Capital, Aligned Bio received a €2.3 million EIC Accelerator grant in early 2025 and is raising a further €7–8 million to bring its technology to market.